25.07.2023 09:00:00
|
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOT
NEW YORK, July 25, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Chinook Therapeutics, Inc. (NASDAQ: KDNY)'s sale to Novartis AG for $40.00 per share in cash. Chinook shareholders will also receive contingent value rights providing for payment of up to $4.00 per share upon the achievement of certain future regulatory milestones with respect to Chinook's lead product candidate, atrasentan. If you are a Chinook shareholder, click here to learn more about your rights and options.
Eneti Inc. (NYSE: NETI)'s sale to Cadeler A/S for 3.409 Cadeler shares for each Eneti share. Upon completion of the transaction, Eneti shareholders will own approximately 40% of the combined company. If you are an Eneti shareholder, click here to learn more about your rights and options.
Talaris Therapeutics, Inc. (NASDAQ: TALS)'s merger with Tourmaline Bio, Inc. Talaris shareholders immediately prior to the proposed transaction are expected to own approximately 21.3% of the combined company. If you are a Talaris shareholder, click here to learn more about your rights and options.
Quotient Technology Inc. (NYSE: QUOT)'s sale to Neptune Retail Solutions for $4.00 per share in cash. If you are a Quotient shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-kdny-neti-tals-quot-301884688.html
SOURCE Halper Sadeh LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Talaris Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |